NEW DELHI: The Lancet Journal late on Thursday retracted the controversial study on hydroxychloroquine which said the repurposed anti-malaria drug increased the risk of mortality in covid-19 patients as the company that collated the data, Surgisphere, did not cooperate with the review. “Our independent peer reviewers informed us that Surgisphere would not transfer the full dataset, client contracts, and the full ISO audit report to their servers for analysis as such transfer would violate client agreements and confidentiality requirements.
As such, our reviewers were not able to conduct an independent and private peer review and therefore notified us of their withdrawal from the peer-review process after severe criticism for the quality of